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The kidney has a cortico-medullary interstitial gradient of
decreasing pH and increasing concentrations of sodium
chloride and urea, but the influence of these gradients on
receptor signaling is largely unknown. Here, we measured
G-protein coupled receptor function in LLC-PK1 cells acutely
exposed to conditions mimicking different kidney regions.
Signaling through the parathyroid hormone receptor,
normally expressed in the cortex, was greatly reduced at an
acidic pH similar to that of the inner medulla. Parathyroid
hormone receptor, tagged with green fluorescent protein,
showed no ligand-induced internalization. In contrast, under
both acidic and hyperosmotic conditions, vasopressin
increased intracellular cAMP, and upon binding to its type 2
receptor (V2R) was internalized and degraded. Dose-
displacement binding assays with selective vasopressin/
oxytocin receptor ligands under inner medullary conditions
indicated a shift in the V2R pharmacological profile. Oxytocin
did not bind to the V2R, as it does under normal conditions
and the vasopressin type 1 receptor (V1R) had reduced
affinity for vasopressin compared to the V2R in low pH and
high osmolality. We suggest that the cortico-medullary
gradient causes a receptor-specific selectivity in ligand
binding that is of functional significance to the kidney. While
the gradient is important for urinary concentration, it may
also play a substantial role in fine-tuning of the vasopressin
response through the V2R.
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The antidiuretic hormone vasopressin (VP) binds to VP
receptor type 1 (V1R), VP receptor type 2 (V2R), as well as
the oxytocin receptor,1–4 which are all members of the seven
membrane spanning G-protein-coupled receptor family.
Ligand stimulation of V1R, which is coupled to Gq, leads
to an increase in intracellular calcium. In contrast, both V2R
and oxytocin receptor are coupled to Gs, and VP binding to
these receptors results in an increase in intracellular cAMP.
Although activation of these receptors has several effects in
the brain and peripheral organs,5–13 the major physiological
role of VP is to stimulate water reabsorption in the kidney.
VP binding to the V2R, expressed in kidney-collecting duct
principal cells, leads to G-protein-induced activation of
adenylyl cyclase14–16 and an increase of intracellular cAMP.17
This results in the cell surface accumulation of the AQP2
water channel in principal cells and increased water
reabsorption.18–21 After stimulation, VP-bound V2R is
desensitized and downregulated,22,23 a process that involves
V2R lysosomal degradation.23–25 Binding of VP to the V2R
also affects urea and sodium transport and progressively
increases concentrations of both sodium and urea in the renal
medullary interstitium. This process is important for the
generation of the corticopapillary interstitial gradient
(Figure 1) that is necessary for urine concentration.26–31
The V2R is expressed in principal cells of all parts of the
kidney-collecting duct, from the cortex to the tip of the
papilla32 and the composition of the kidney interstitium is
known to vary in pH and osmolarity from cortex to the outer
and inner medulla. The cortical interstitium has a neutral pH
(7.4) and is isoosmotic (300 mOsm/kg). However, these
conditions gradually change along the collecting duct to
produce a more extreme environment in which the renal
tubules function. At the tip of the papilla, the interstitium is
acidic (pH 5.7±0.2)33–35 and hyperosmotic (up to
1200 mOsm/kg in humans and 41200 mOsm/kg in rodents
and many other mammals).36–38 Thus, VP must be able to
bind to the V2R in environments ranging from isoosmotic/
neutral pH to hyperosmotic/acidic pH. The functional
requirement of the V2R to be active under the increasingly
acidic and hyperosmotic conditions with high urea concen-
trations that are encountered as the collecting duct descends
into the inner medulla, contrasts with that of several other
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receptors that are present mainly in the renal cortex and
outer medulla. These include the parathyroid hormone
receptor (PTHR) and the angiotensin II receptor. Interest-
ingly, the V1R, which is present in the renal vasculature, is
also found in collecting ducts but is more abundant in the
cortex than in the outer or inner medulla.
The role of the medullary environment on VP binding has
not been studied in detail. Earlier work from our lab showed
that at neutral pH, intracellular cAMP accumulation
following VP-induced V2R activation is further increased
by hypertoncity.39 cAMP production decreased following
addition of urea, but when both sodium chloride (NaCl) and
urea were added at gradually increasing concentrations,
intracellular cAMP content increased.39 The combined effect
of acidification, NaCl and urea, however, remains unknown.
Recent work from our group and others has shown that
following VP binding at neutral pH, V2R activity is
downregulated by lysosomal degradation.24,25 We suggested
that this degradation results from the inability of V2R to
dissociate from its ligand, VP, in acidic early endosomes. The
association between the V2R and VP may have adapted and
evolved to allow a tight ligand–receptor interaction that is
maintained even under acidic conditions such as those of the
inner medulla. It is well established that in contrast to V2R,
most ligands detach from their cognate receptor in acidic
endosomes before their subsequent lysosomal degradation,
whereas the receptor is recycled back to the cell surface.40
Thus, it is important to understand the pharmacology of the
V2R under conditions that reflect the prevailing environment
of the inner medulla (low pH, high tonicity, and high
concentrations of urea) as well as those of other kidney
regions.
The purpose of this study was to characterize the
pharmacology and downregulation of V2R under conditions
mimicking those occurring in the renal cortex and medulla.
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Figure 1 | The collecting duct is exposed to a corticomedullary
gradient. The kidney collecting duct is exposed to a
corticomedullary gradient of decreasing pH and increasing
concentrations of NaCl and urea.
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Figure 2 | Under conditions of acidic pH the affinity of VP for V2R is lower than at neutral pH. LLC-FLAG-V2R cells were grown to
confluence following incubation with different concentrations of [3H]VP at pH 7.4 (’) and pH 5.5 (m) for 3 h at 41C (a). Scatchard plot
representation of binding saturation experiments at pH 7.4 (’) and pH 5.5 (m) (b). Means of triplicate values are shown, representative of
data from four independent experiments (mean±s.e.m.).
Table 1 | The effect of pH and hypertonicity on VP binding to
V1R and V2R
IC50 (nM) (n)
Receptor 7.4 7.4 NaCl 5.5 5.5 NaCl
V1R 6.0±1.1 (3) 8.8±1.2 (3) 7.3±1.8 (3) 29.3±15.0 (3)
V2R 1.5±0.4 (3) 2.6±0.6 (3) 9.1±1.3 (3) 7.8±2.1 (3)
VP, vasopressin; V1R and V2R, VP receptor types 1 and 2.
The results shown represent three independent experiments (mean±s.d.).
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We show that V2R indeed has properties that allow it to
function in the inner medullary environment, in contrast to
the PTHR, which is located mostly in the cortex and outer
medulla. Our data also show that of all selective VP/oxytocin
receptor ligands tested, VP displays the highest affinity for
V2R under all conditions tested.
RESULTS
Effects of acidity and hyperosmolality on VP binding to VP
receptors
[3H]-VP saturation of binding sites in LLC-FLAG-V2R cells
was dose dependent at both pH 7.4 and 5.5 (Figure 2),
reaching maximal binding capacity under both conditions
(Figure 2a). Scatchard analysis revealed one class of high-
affinity binding sites (Figure 2b). The affinity constant (KD)
of [3H]-VP for V2R under acidic conditions was 10-fold
lower than under conditions of neutral pH (78±34 and
7±3 nM, respectively) but maximal V2R-binding capacity
under both conditions was not significantly different
(78,000±6000 and 49,800±13,400 binding sites per cell,
respectively). A similar result was observed by dose–displacement
of [3H]-VP with VP on COS cells transfected with either V1R
or V2R (Table 1). Thus, V2R displayed a reduced affinity for
VP under acidic conditions, whereas an increase of
osmolality had no effect on V2R affinity for VP. In contrast,
a combination of acidity and increased osmolality reduced
V1R affinity for VP.
The effect of an acidic buffer and hyperosmolality on the
binding of VP analogs to the V2R was studied by performing
[3H]-VP dose–displacement experiments using VP, [deami-
no-Cys1, D-Arg8]-VP (DDAVP), Manning’s compound, and
oxytocin at pH 7.4 or 5.5 in the presence or absence of
hypertonic NaCl. In all cases, [3H]-VP was displaced in a
dose-dependent manner. At neutral pH, V2R affinity for VP
Table 2 | Affinity of VP analogs for the V2R at pHs 7.4 and 5.5 under isoosmotic and hyperosmotic conditions
VP analog
KD (nM) at
pH 7.4, 300 mOsm
KD (nM) at
pH 7.4, 600 mOsm
KD (nM) at
pH 5.5, 300 mOsm
KD (nM) at
pH 5.5, 600 mOsm
VP 3.67±0.43 (3) 20.34±9.19 (3) 88.22±34.08 (3) 142.40±59.06 (3)
DDAVP 32.21±5.00 (3) 81.44±44.53 (3) 600.90±160.71 (3) 754.92±407.25 (3)
Manning’s compound 178.00±54.19 (3) 42.47±44.53 (3) 144.40±50.00 (3) 34.93±12.38 (3)
OT 678.90±192.71 (3) ND b100,000 (3) ND
DDAVP, [deamino-Cys1, D-Arg8]-VP; ND, not defined; OT, oxytocin; VP, vasopressin.
The results shown represent three independent experiments (three) done in triplicate (mean±s.d.).
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Figure 3 | Hypertonicity increases cAMP signaling of VP-stimulated V2R, but decreases signaling of PTH stimulated PTHR. cAMP
accumulation was tested using a cAMP assay as described in section ‘Materials and Methods’. cAMP accumulation was studied in the
presence or absence of 1 mM VP or PTH (open bars and closed bars, respectively). VP was used to stimulate LLC-FLAG-V2R and PTH was used
to stimulate LLC-PTHR cells at pH 7.4 (a, c) or at pH 5.5 (b, d). Experiments were performed in triplicate. The number of experiments
performed is shown in parenthesis. Data are shown as mean±s.e.m. Maximal forskolin response at pH 7.4, 300 mOsm for LLC-FLAG-V2R is
11,234±135 fmol/106 cells. Maximal forskolin response at pH 7.4, 300 mOsm for LLC-PTHR is 12,429±491 fmol/106 cells. We compared by
t-test the amount of cAMP before VP stimulation at pH 7.4, 300 mOsm to other nonstimulated conditions. Intracellular cAMP accumulation
following VP stimulation at pH 7.4, 300 mOsm was compared with VP-induced cAMP accumulation occurring under all other conditions.
Significance of t-test is indicated by asterisks.
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was high (KD of 3.67±0.43 nM) (Table 2). V2R affinity for
DDAVP was 10-fold lower than for VP whereas its affinity for
the Manning’s compound and oxytocin was 46- and 179-fold
lower than for VP, respectively (Table 2). This pharmacological
profile is different from that observed under conditions where
either osmolality or pH was modified (VP 4 Manning’s
compound 4 DDAVP). Oxytocin, which has 163 times less
affinity for V2R as compared with VP, was unable to displace
[3H]-VP from V2R under acidic conditions. This modified
pharmacological profile was even more significant when both
pH and osmolality were simultaneously changed (Manning’s
compound 4 VP 4 DDAVP).
Effect of acidity and hyperosmolality on V2R downstream
effectors and signaling
cAMP accumulation induced by forskolin decreased 1.5-fold
under acidic conditions, as compared with that induced
under conditions of neutral pH (data not shown). Intracel-
lular cAMP was increased by VP stimulation under both
normal and acidic conditions, and VP-induced cAMP
accumulation was enhanced by tonicity (Figure 3a and b).
Similar experiments performed in the presence of sucrose
suggest that the effect of NaCl on cAMP is not due to a
specific effect of either sodium or chloride. In contrast to the
positive effect of hypertonicity on V2R, intracellular cAMP
levels in cells expressing PTHR were reduced in hypertonic
medium containing PTH under both normal and acidic
conditions (Figure 3c or d). Thus, in contrast to VP signaling,
PTH signaling was significantly inhibited by hypertonicity
(Figure 3c and d). We then investigated the combined effect
of NaCl and urea on cAMP generation under conditions of
varying pH. For this purpose, we used neutral pH medium
mimicking the kidney outer medullary environment and a
second medium of pH 5.5, mimicking the kidney inner
medulla (Figure 4). We found that in ‘outer medullary’
conditions (600 mOsm/kg, pH 7.4), cAMP generation was
increased (Figure 4). Results of the present study (Figure 3a)
and our previous study39 show that NaCl added at pH 7.4
increases VP-induced cAMP signaling. We now conclude that
60 mOsm/kg urea does not diminish this effect at a neutral
pH. Furthermore, VP causes cAMP content to significantly
increase even under conditions mimicking the inner medulla
(1200 mOsm/kg, pH 5.5), although this effect was reduced as
compared with the signal generated under less extreme ‘outer
medullary’ conditions, but did not change in comparison to
control conditions (pH 7.4, 300 mOsm/kg).
Effect of acidity and hyperosmolality on V2R internalization
and trafficking
We have shown that even under harsh conditions mimicking
the inner medulla, VP significantly increases cAMP genera-
tion (Figure 4). To further investigate V2R function, we
examined ligand-induced V2R internalization occurring
under these conditions. As shown in Figure 5 and confirmed
by quantification (Figure 5g), VP induced an internalization
of V2R-green fluorescent protein (GFP) under all conditions
tested (Figure 5). Similar results were found with two other
LLC-PK1 cell lines expressing V2R (data not shown),
indicating that this is not a clonal effect. Similar experiments
were performed on LLC-PK1 cells stably expressing GFP
coupled to either the PTHR (PTHR–GFP) or the angiotensin
II receptor (AT1R–GFP) (Figure 6). In the absence of ligands,
both receptors were localized at the plasma membrane under
normal (Figure 6a and e) or acidic and hyperosmotic
conditions (Figure 6c and g). In normal isoosmotic medium
at neutral pH, all receptors were internalized in the presence
of their respective ligands (Figure 6b and f). In the absence of
ligands, an acidic pH together with the addition of both NaCl
and urea did not affect the baseline localization of these
receptors. However, although addition of PTH did not
induce PTHR–GFP internalization under these same condi-
tions, AT1R–GFP was internalized on angiotensin II addition
(Figure 6d and h). Quantification of PTHR–GFP fluorescence
showed a reduction of membrane fluorescence and an
increase of cytoplasmic fluorescence resulting from PTH
internalization under conditions mimicking the outer
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Figure 4 | cAMP accumulation following V2R stimulation by VP occurs under ‘harsh’ conditions mimicking those of the inner
medulla. cAMP accumulation was studied in the presence or absence of 1 mM VP (open bars and closed bars, respectively). VP was diluted in
normal and acidic buffer in the presence of increasing amounts of sodium and urea. Experiments shown represent an average of three
different experiments performed in triplicate (mean±s.e.m.). Maximal forskolin response at pH 7.4, 300 mOsm is 12 ,270±467 fmol/106
cells.
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medullary environment. The membrane/cytosolic fluores-
cence ratio was reduced from 0.56±0.01–0.48 (cortical
environment) and 0.38 (outer medullary environment)
±0.01, whereas no significant decrease was observed under
conditions mimicking the inner medullary environment. This
result suggests that corticomedullary gradients differentially
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Figure 5 | V2R internalizes following VP stimulation under ‘harsh’ conditions mimicking those of the inner medulla. LLC-V2R-GFP
cells were incubated in the absence (a, c, and e) or the presence of 1 mM VP (b, d, and f) under conditions mimicking normal (upper panel),
outer (middle panel), and inner medulla (lower panel). In (d), a perinuclear accumulation of V2R was observed after internalization. This
phenomenon is currently under more detailed investigation. These results are representative of three independent assays. Three other
assays were performed and analyzed by epifluorescence microscopy. Quantification of membrane fluorescence was analyzed using IPLab
software (g) as described in section ‘Materials and Methods’; mean±s.e.m.
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affect receptor internalization. Western blot analysis showed
that internalized V2R is degraded under all conditions
(Figure 7). Thus, after internalization, V2R is degraded in a
similar quantitative manner to that previously reported.24,25
DISCUSSION
The interstitium of the kidney papilla is a harsh environment
in which VP and V2R interact to modify the behavior of
specific target cells. Cell signaling becomes a challenge when
Untreated cells
Untreated cells
pH 7.4
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Figure 6 | AT1R receptors internalize following AngII stimulation under ‘harsh’ inner medullary conditions, whereas PTH-stimulated
PTHR does not. LLC-PTHR-GFP (a–d) and LLC-AT1R-GFP (e–h) cells, stably expressing either PTHR-GFP or AT1R-GFP were incubated in
the absence (a, c and e, g) or presence of 1 mM of their respective agonists (b, d and f, h). Cells were incubated with either neutral (a, b and
e, f) or acidic hyperosmotic medium (c, d and g, h). Sequential images were acquired using spinning disk confocal microscopy. Acquired
images of cells taken before and after 30 min of agonist stimulation are representative of four independent experiments.
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ligands and their cognate receptors face conditions that are
known to affect protein–protein interactions. These condi-
tions include an acidic pH, high concentrations of NaCl, and
high concentrations of urea, a compound that affects protein
conformation. On the basis of physiological data, it is clear
that VP and V2R can indeed interact in such environments,
which occur in parts of the kidney medulla. Here, we present
data quantifying this interaction under various conditions
that partially reflect the in vivo milieu in which V2R ligand
stimulation, signaling, and downregulation occur. In this
study, we focused our attention on major components of the
interstitial environment (NaCl, urea, and pH). However, the
presence of other constituents such as reactive oxygen
species,41,42 amino acids,43 and organic osmolytes such as
betaine, myo-inositol44–46 adds to the complexity of the
interstitial environment in which the tubular epithelial cells
must function.
First, we studied the effects of environmental acidification
on the VP–V2R interaction. We show that VP binds to its
receptor and induces an increase of cAMP in an acidic
environment, although the affinity of VP for its receptor was
reduced under these conditions. A previous study suggested
that VP interacts with V2R in LLC-PK1 cells exposed to an
even more acidic medium (pH 3).47 This property of VP to
bind its receptor under acidic conditions indicates that VP
most likely does not detach from its receptor in acidic
endosomes (pH 5.5–6.5). We suggest that the ‘acidic-
resistance’ of the VP–V2R interaction leads to the delivery
of undissociated ligand–receptor complexes to lysosomes
where they are degraded, as previously reported by our group
and others.48,49
Although acidification of the medium did not significantly
affect the affinity of VP for its receptor, it did have interesting
effects on the pharmacological profile of the V2R with respect
to its affinity for different selective VP/oxytocin receptor
ligands. In particular, our data suggest that acidification
might be important in discriminating between effects
induced by VP and oxytocin in the kidney. Oxytocin
moderately increases urine osmolality in VP-deficient Brat-
tleboro rats, which have a reduced capacity to generate a
corticomedullary gradient.50–52 Recent data from the Schrier
laboratory52 have shown that this occurs in part by
modulating AQP2 water channel recycling, supporting our
earlier ‘pre-aquaporin’ observations that water channel
recycling is stimulated by oxytocin.50–52 Nevertheless, the
acute antidiuretic effect of oxytocin was not observed in
normal rat whereas its natriuretic effect was observed in
normal or VP-deficient rats.53 However, oxytocin given to
women to induce labor can be associated with hyponatremia
via an effect on the V2R.54,55 Our data suggest that this effect
might be restricted to regions of the collecting duct that are
not exposed to the harsh interstitial conditions that we show
here reduces affinity of the V2R for oxytocin. In this respect,
it is important to note that more solute-free water
reabsorption occurs in the cortical collecting duct than in
the medulla under antidiuretic conditions. On the basis of
our present results, environmental acidification has a drastic,
negative effect on oxytocin binding. Furthermore, the
presence of pH and osmotic gradients may be involved in
the fine tuning of VP activation along the collecting duct
where V1R and V2R are both present in principal cells.29,56–58
We found that VP interacts differently with the V1R and V2R
under acidic and hyperosmotic conditions. Hyperosmotic
conditions only slightly reduced the affinity of VP for the
V1R and V2R at pH 7.4. Hyperosmotic medium can increase
or reduce the affinity of ligands for other receptors as
observed for angiotensin and bradykinin, respectively.59
Interestingly, we found that a combination of hyperosmol-
ality and an acidic environment has a much greater effect on
reducing VP affinity for the V1R as compared with the V2R.
This result suggests that the corticomedullary gradient may
be involved in site-specific signaling by regulating (reducing)
binding of VP to V1R, a receptor suggested to be a
physiological V2R antagonist in parts of the collecting
duct.60,61 The gradient might also influence other cross-talk
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Figure 7 | VP stimulated V2R-GFP degrades under conditions
of both acidic and neutral pH. V2R-GFP degradation after
4 hours of VP stimulation (at 37 1C) under both neutral and
acidic conditions was studied by Western blot analysis (a).
LLC-V2R-GFP cells were incubated in the absence (lanes 1 and 3)
or presence (lanes 2 and 4) of VP. In the absence of VP, 71 and
55 kDa bands are observed corresponding to intact, glycosylated
V2R and to a degraded fragment of this receptor, respectively. The
presence of VP reduced the intensity of the 71 kDa band (lane 2).
Similar results were observed under acidic conditions (lanes 4–6).
Disappearance of the upper band intensity was quantified in
relation to the intensity of corresponding b-actin bands, used as a
loading control (b). This is a representative blot from three
independent experiments; Mean±SD. ***P40.005 between VP
treated and untreated conditions, ***P40.001 between sample
incubated at pH 5 in the presence of VP and in the presence of
either NaCl or Urea.
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events, such as that occurring between VP and epithelial
growth factor, which has been described in rat inner
medullary membrane preparations.62
Under normal conditions, we found that the presence of
NaCl increases intracellular cAMP levels in response to V2R
ligand stimulation. This result is in agreement with previous
studies performed on LLC-PK1 cells.39,63,64 Similar results
have been observed in isolated rat papillary collecting ducts
and mouse thick ascending limbs.32,65,66 Interestingly,
although acidification of the cell culture medium reduced
ligand affinity and cAMP signaling, simultaneous acidic and
hyperosmotic challenge enhanced intracellular cAMP accu-
mulation arising from V2R ligand stimulation. Rescued
cAMP signaling by hyperosmolality at acidic pH values was
not observed for the PTHR, whose function may, therefore,
be impaired under such extreme environments. Indeed the
PTHR is largely restricted to the cortex and outer medulla of
the kidney.67,68 Thus, in the inner medulla, hyperosmolality
is a key factor regulating VP signaling. Although VP
significantly increased cAMP concentration under conditions
that mimic the harsh environment of the kidney papilla, this
accumulation was reduced by urea. A similar dose-dependent
reduction has been reported previously in in vitro studies in
our lab39 and in previous studies performed on thick
ascending limbs of Henle and on kidney medullary
tissue.69,70
These results are different to the mutually protective and
antiapototic effects of high urea and high salt observed in
inner medullary collecting duct cells71,72 but may provide a
feedback mechanism that negatively regulates the VP
response in vivo by allowing the V2R to monitor, and
respond to, interstitial urea accumulation. In addition to
examining VP binding and cAMP generation, we examined
receptor internalization and found that VP and angiotensin II
each induced endocytosis of their specific receptors and that
this occurred under all conditions tested. In contrast, PTHR
failed to internalize under ‘inner medullary’ conditions.
Internalization of AT1R may be expected as it has been
shown to modulate VP-induced water transport,73,74 whereas
the PTHR is expressed mainly in the cortex and outer
medulla and is not exposed to conditions of extreme pH and
osmolality.
In summary, we show that VP binds to the V2R and
induces cAMP signaling under conditions mimicking the
harsh environment of the kidney inner medulla/papilla.
Hyperosmolality may rescue the partial loss of affinity of the
V2R for its ligand that occurs under acidic conditions. In
addition, osmolality and pH can modify the ligand-binding
characteristics of V2R. Thus, in addition to its well-known
permissive effects on osmotic water transport, the cortico-
medullary gradient has other positive effects on the urinary
concentrating mechanism. These include: (1) increasing
AQP2 expression independently of VP,75–77 (2) increasing
VP binding and signaling via the V2R in acidic conditions,
(3) increasing the efficiency of the VP/V2R association by
reducing affinity of the V2R for oxytocin and reducing the
affinity of the V1R for VP, and (4) increasing cAMP
generation in response to a given concentration of VP.
Importantly, the effects vary between different receptors.
Although we examined the V2R, PTHR, and some aspects of
AT1R function in this report, it is likely that the ligand-
binding characteristics and signaling properties of many
other receptors in the kidney are modulated by the interstitial
environment. This will need to be examined on a case by case
basis in future studies.
MATERIALS AND METHODS
Cell culture and transfection
All cell culture reagents were obtained from GIBCO-BRL (Grand
Island, NY, USA). LLC-PK1 cells stably expressing either N-terminus
FLAG tagged V2R (LLC-FLAG-V2R), C-terminus GFP tagged V2R
(LLC-V2R-GFP), or PTHR (HKRK-B7, gift of Dr Gardella,
Endocrine Unit MGH) were cultured in DMEM, 10% FBS,
neomycin (1 mg/ml) as previously described.22,24,78 COS cells were
grown in a similar medium lacking neomycin. COS and LLC-PK1
cells were transfected with vectors containing V1R or V2R
(University of Missouri-Rolla, cDNA Resource Center, MO, USA)
or angiotensin receptor type 1 conjugated to GFP (AT1R-GFP) (Gift
of Dr Guillemette, University of Sherbrooke, Canada). Transfections
were carried out with effectene according to Qiagen protocol
(Hilden, Germany).
[3H]-VP binding assays
Unless otherwise stated, all chemicals were purchased from Sigma
(St Louis, MO, USA). The dose–displacement and saturation
binding assays were both performed under either normal or acidic
conditions. [3H]-VP binding site saturation was performed under
normal conditions as previously described.22 [3H]-VP (44.0 Ci/
mmol, Perkin-Elmer, Boston, MA, USA) was diluted in 20 mM
sodium phosphate buffer pH 7.4, 1 mg/ml glucose, 1 mM CaCl2,
1 mM MgCl2, 3.5 mM KCl, and 137 mM NaCl. To obtain acidic
conditions, sodium phosphate was replaced by 20 mM MES (2-N-
morpholino)ethanesulfonic acid) pH 5.5. For both conditions, an
increasing amount of [3H]-VP (up to 120 nM) was added to each
well, in triplicate for each experiment. Nonspecific binding was
determined in the presence of excess unlabeled VP (1mM). After
incubation (3 h, 4 1C), washed cells were solubilized in 500ml of
NaOH (0.1 N). Radioactivity signals were quantified with a liquid
scintillation analyzer Tricarb 2200 CA (Packard, The Netherlands).
[3H]-VP (10 nM) was displaced by increasing amounts of [Arg8]-
VP (VP), oxytocin, [b-mercapto-b,b-cyclopentamethylenepropio-
nyl1, O-me-Tyr2, Arg8]-VP (Manning’s compound), or DDAVP on
LLC-FLAG-V2R cells. Each dose–displacement curve was performed
under neutral and acidic conditions in buffers of 300–600 mOsm
(following addition of NaCl). The nonspecific binding was defined
in the presence of VP (1 mM). Dose–displacement of [3H]-VP by VP
under similar buffer conditions was also performed on COS cells
transfected with V1R or V2R as described above.
cAMP assays
Intracellular cAMP levels were measured with the Biotrak kit in the
constant presence of 3-isobutyl-1-methyl-xanthine (IBMX, 1 mM), a
phosphodiesterase inhibitor (Amersham Biosciences Corp., Piscat-
way, NJ, USA) as previously described.22,24 Intracellular cAMP
accumulation was evaluated in either LLC-FLAG-V2R or LLC-
PTHR cells after incubation in the presence of 1 mM VP or PTH,
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respectively. Cells were incubated in the presence of either VP or
PTH diluted in normal or acidic isotonic buffer (300 mOsm) and in
normal or acidic hyperosmotic buffer (900 and 1200 mOsm or
30 min at 37 1C. All cAMP assays were performed on quadruplicate
where maximal cAMP elevation was evaluated in the presence of
forskolin (10mM). The combined effect of urea and NaCl on VP-
induced intracellular cAMP accumulation in LLC-V2R-GFP cells
was studied. Cells were incubated in the presence or absence of VP
(1mM) for 30 min in normal or acidic buffer to which urea and NaCl
were added (120 mOsm/kg NaCl and 60 mOsm/kg urea, and
225 mOsm/kg NaCl and 450 mOsm/kg urea, respectively).
Spinning disc confocal microscopy
V2R-GFP internalization in the presence of VP in neutral isotonic
buffer, and buffers mimicking outer and inner medullary conditions
(see section ‘cAMP assays’) was followed in real-time, using spinning
disc confocal microscopy (LCI Ultra View, Perkin-Elmer). The
microscope was equipped with an environmental chamber to
regulate temperature (37 1C) and atmosphere (95% O2/5% CO2).
The cell culture medium in the glass-bottomed dishes (WPI,
Sarasota, FL, USA) containing cells was replaced by different media
as indicated in the figure legends, and cells were placed in the
environmental chamber. After 15 min, ligand (VP, PTH, or
angiotensin II) was then added at a final concentration of 1 mM. In
order to reduce fluorescence bleaching, images of cells were taken
before and after 30 min of agonist stimulation. At each time point,
stacks of images were taken at 0.2mm intervals along the z axis, and a
three-dimensional image was reconstructed using Volocity software
(Improvision Inc., Waltham, MA, USA). In parallel, quantification of
fluorescence at the membrane and in intracellular compartments in
the presence or absence of ligands was performed on cells fixed in PBS
containing 4% paraformaldehyde and 5% sucrose. Quantification was
performed using IPlab software (BD Biosciences, CA, USA). Briefly,
the number of pixels contained in an outline enclosing the plasma
membrane or the cell cytoplasm was quantified as integrated optical
density 23 values. The mean plasma membrane/cytoplasm sorting
index, defined as the intregated optical density of the plasma
membrane divided by the cytoplasmic intregated optical density,
±s.e.m from at least 20 cells was determined.
Electrophoresis and Western blot analysis
The effect of NaCl and urea on V2R degradation was examined by
Western blot analysis as already described.24 In brief, LLC-V2R-GFP
cells were incubated for 4 h in the presence or absence of VP (1 mM),
diluted in either normal or acidic medium containing either NaCl or
urea. Protein (20 mg) solubilized in RIPA buffer (Boston Biopro-
ducts, MA, USA), 4 mM EDTA, and protease inhibitor cocktail
(Roche Diagnostics GmbH, Germany) was separated on 4–12% Bis-
Tris-PAGE gel and transferred onto PDVF membranes using the
IBlot system according to the manufacturer’s protocol (Invitrogen,
Carlsbad, CA, USA). The presence of V2R-GFP was detected using a
polyclonal rabbit anti-GFP antibody (0.4 mg/ml, Molecular probe,
OR, USA). The acid-tripped membranes were incubated with a
mouse anti-b-actin antibody (0.2 mg/ml, Chemicon International,
Temecula, CA, USA) and used as loading control. All band
intensities were quantified using a video densitometer and Kodak
ID software (Kodak, New Haven, CT, USA).
Statistic and analysis of binding data
The values of IC50, KD, and Bmax as well as the values of EC50 in
cAMP assays were analyzed using a nonlinear least squares fitting
program (GraphPad PRISM, GraphPad Software Inc., CA, USA)
and expressed as means±s.e.m. Statistical analyses were performed
using the unpaired Student’s t-test.
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